VANCOUVER, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…
— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 — — NDA is…
- ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality…
Leading distributor of surgical robotics to elevate MMI’s presence in ItalyJACKSONVILLE, Fla.--(BUSINESS WIRE)--MMI, (Medical Microinstruments, Inc.), a robotics company dedicated…
Pioneering Collaboration Unveils Charitable Lecture on Cutting-Edge Cancer PreventionLOS ANGELES, CA / ACCESSWIRE / January 10, 2024 / In a…
Strong SOPHiA DDM™ adoption and analysis volume contributes to continued revenue growth Liquid biopsy and HRD on SOPHiA DDM™ Platform…
NORTHAMPTON, MA / ACCESSWIRE / January 10, 2024 / Gilead Sciences:When employees at Gilead's recently opened New Jersey office need…
Halifax, Nova Scotia--(Newsfile Corp. - January 10, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")…
Collaboration streamlines patient access to oncology clinical trials; further expands Parexel's Site Alliance Network across Asia/PacificDURHAM, N.C. and TOKYO, Jan. 10,…
First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and…